| Perioperative myeloid cell remodeling shapes CAR-T cell efficacy in glioblastoma | Nature communications |  | | 2026 | 32 | 21 |
|
| Unveiling the molecular architecture of T cells and immune synapses with cryo-expansion microscopy | Cell reports | | | 2026 | 8 | 24 |
|
| MYCT1–IFITM2/3 interaction links endothelial endolysosomal trafficking to white adipose tissue expansion | The Journal of experimental medicine | | | 2026 | 11 | 9 |
|
| Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma | JCI insight | | | 2025 | 8 | 31 |
|
| Targeting HIF-2α in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade | Cellular and molecular life sciences | | | 2025 | 195 | 152 |
|
| Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma | Journal for immunotherapy of cancer | | | 2025 | 8 | 22 |
|
| Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturing | Molecular therapy. Methods & clinical development | | | 2025 | 68 | 218 |
|
| PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma | Cancer immunology research | | | 2024 | 310 | 367 |
|
| A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy | Molecular therapy. Oncology | | | 2024 | 223 | 204 |
|
| Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro | Radiotherapy and oncology | | | 2024 | 121 | 65 |
|
| Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages | Cell communication and signaling | | | 2024 | 145 | 82 |
|
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | | 2024 | 112 | 97 |
|
| Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy | Cells | | | 2023 | 126 | 338 |
|
| PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma | | | | 2023 | 252 | 794 |
|
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | | 2023 | 334 | 274 |
|
| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models | Biomedicines | | | 2023 | 67 | 297 |
|
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | | 2022 | 266 | 284 |
|
| Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer | iScience | | | 2022 | 250 | 211 |
|
| Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma | Frontiers in Immunology | | | 2021 | 471 | 565 |
|
| Emerging Trends for Radio-Immunotherapy in Rectal Cancer | Cancers | | | 2021 | 64 | 204 |
|
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | | | 2021 | 344 | 167 |
|
| Metataxonomic and Metabolic Impact of Fecal Microbiota Transplantation From Patients With Pancreatic Cancer Into Germ-Free Mice: A Pilot Study | Frontiers in cellular and infection microbiology | | | 2021 | 353 | 209 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 353 | 246 |
|
| Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors | International Journal of Molecular Sciences | | | 2020 | 303 | 506 |
|
| An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | | | 2020 | 493 | 352 |
|
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | | | 2020 | 468 | 365 |
|
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | | | 2020 | 361 | 200 |
|
| Stratégies de vaccination thérapeutique dans le glioblastome | Medecine Sciences | | | 2020 | 224 | 460 |
|
| Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review | Journal for immunotherapy of cancer | | | 2020 | 210 | 452 |
|
| Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma | Molecular and Cellular Proteomics |  | | 2019 | 444 | 2 |
|
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | | 2019 | 861 | 898 |
|
| Current strategies for vaccination in glioblastoma | Current Opinion in Oncology | | | 2019 | 409 | 5 |
|
| Peptides as cancer vaccines | Current Opinion in Pharmacology | | | 2019 | 432 | 4 |
|
| Actively personalized vaccination trial for newly diagnosed glioblastoma | Nature | | | 2019 | 576 | 12 |
|
| Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | | | 2019 | 379 | 252 |
|
| [Retracted] Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Molecular and Cellular Proteomics | | | 2018 | 451 | 24 |
|
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | | | 2018 | 675 | 451 |
|
| First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies | OncoImmunology | | | 2017 | 667 | 9 |
|
| Immunothérapie des gliomes : illusion ou espoir ? | Bulletin du cancer | | | 2017 | 435 | 0 |
|
| ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells | EMBO Journal | | | 2017 | 632 | 10 |
|
| Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | Cancer Cell | | | 2017 | 524 | 5 |
|
| Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? | Frontiers in Oncology | | | 2016 | 544 | 494 |
|
| Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness | Biomaterials | | | 2016 | 573 | 5 |
|
| Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | | | 2016 | 469 | 0 |
|
| Identification of glioma-associated antigens for brain tumor immunotherapy | | | | 2015 | 686 | 622 |
|
| Immunotherapy of Brain Tumors | Progress in tumor research | | | 2015 | 597 | 0 |
|
| Immunotherapy for glioma: from illusion to realistic prospects? | American Society of Clinical Oncology educational book | | | 2014 | 1,288 | 684 |
|
| Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response | International journal of cancer | | | 2014 | 766 | 530 |
|
| Extrachromosomal driver mutations in glioblastoma and low-grade glioma | Nature communications | | | 2014 | 781 | 297 |
|
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) | European urology | | | 2013 | 621 | 0 |
|
| The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma | Biomaterials | | | 2013 | 751 | 6 |
|
| Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy | Brain | | | 2012 | 723 | 1,753 |
|
